SUMMARY Unresectable glioblastoma (GBM) cells in the invading tumor edge can act as seeds for recurrence. The molecular and phenotypic properties of these cells remain elusive. Here, we report that the invading edge and tumor core have two distinct types of glioma stem-like cells (GSCs) that resemble proneural (PN) and mesenchymal (MES) subtypes, respectively. Upon exposure to ionizing radiation (IR), GSCs, initially enriched for a CD133 + PN signature, transition to a CD109 + MES subtype in a C/EBP-β-dependent manner. Our gene expression analysis of paired cohorts of patients with primary and recurrent GBMs identified a CD133-to-CD109 shift in tumors with an MES recurrence. Patient-derived CD133 − /CD109 + cells are highly enriched with clonogenic, tumor-initiating, and radiation-resistant properties, and silencing CD109 significantly inhibits these phenotypes. We also report a conserved regulation of YAP/TAZ pathways by CD109 that could be a therapeutic target in GBM.
To define the topology of the skeletal muscle ryanodine receptor (RyR1), enhanced GFP (EGFP) was fused in-frame to the C terminus of RyR1, replacing a series of C-terminal deletions that started near the beginning or the end of predicted transmembrane helices M1-M10. The constructs were expressed in HEK-293 (human embryonic kidney cell line 293) or mouse embryonic fibroblast (MEF) cells, and confocal microscopy of intact and saponin-permeabilized cells was used to determine the subcellular location of the truncated fusion proteins. The fusion protein truncated after M3 exhibited uniform cytoplasmic fluorescence, which was lost after permeabilization, indicating that proposed M , M , M1, M2, and M3 sequences are not membrane-associated. The fusion protein truncated at the end of the M4 -M5 loop and containing M4 was membrane-associated. All longer truncated fusion proteins were also associated with intracellular membranes. Mapping by protease digestion and extraction of isolated microsomes demonstrated that EGFP positioned after either M5, the N-terminal half of M7 (M7a), or M8 was located in the lumen, and that EGFP positioned after either M4, M6, the C-terminal half of M7 (M7b), or M10 was located in the cytoplasm. These results indicate that RyR1 contains eight transmembrane helices, organized as four hairpin loops. The first hairpin is likely to be made up of M4a-M4b. However, it could be made up from M3-M4, which might form a hairpin loop even though M3 alone is not membrane-associated. The other three hairpin loops are formed from M5-M6, M7a-M7b, and M8 -M10. M9 is not a transmembrane helix, but it might form a selectivity filter between M8 and M10.S keletal muscle contraction is initiated by activation of a Ca 2ϩ release channel (ryanodine receptor isoform 1 or RyR1) located in the junctional terminal cisternae of the sarcoplasmic reticulum. Activation occurs through physical interaction with the dihydropyridine receptor, located in the transverse tubular membrane, where it is directly apposed to the ryanodine receptor (1, 2). Four RyR monomers, each of 565 kDa, assemble as a homotetrameric complex and transmembrane sequences from each of the four monomers interact to form the ion-conducting pore (3). Hydropathy profiles of RyR1 (4, 5), based on criteria defined by Kyte and Doolittle (6), indicate that the bulk of the RyR1 molecule is cytoplasmic and that 4-12 transmembrane sequences lie within the C-terminal one-tenth to one-fifth of the molecule. Among the predicted transmembrane sequences, four potential transmembrane sequences are clearly more hydrophobic than others, with hydropathy indices between 2.0 and 2.9. These four sequences, amino acids Phe-4564-Tyr-4580, Pro-4641-Leu-4664, Gln-4836 -Phe-4859, and Ile-4918 -Ile-4937, were designated M1-M4 and were proposed to form two hairpin loops in the topological model proposed by Takeshima et al. (4). In a second model, proposed by Zorzato et al. Earlier attempts have been made to elucidate the structure and topology of RyR. Proteolytic digestion of RyR1 ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.